Healthcare Leaders Should Look Beyond the Hype Around AI, One Expert Says - HCI Innovation Group
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
Skip to main contentNavigating the shift from volume to value in healthcareJoseph Villa emphasizes the importance of understanding AI's true capabilities in healthcareOct. 10, 20263 min read Pietje Kobus-McAllisterWinter is coming, Joseph Villa, founder and CEO of Bigbee Labs, Inc., predicts regarding the future of artificial intelligence (AI). Villa shared his thoughts at the second annual HealthAI summit, hosted by HealthInno on October 8 in Albuquerque, NM. The summit drew health leaders and medical professionals from New Mexico and beyond. The audience was invited to write their questions and concerns about AI on sticky notes and post them on a wall. Later in the day, notes with solutions and ideas would be added.
As AI becomes increasingly prominent in healthcare, organizations must distinguish between what the technology can actually do and what vendors claim it can do, Villa said.
This article is an excerpt. To read the full content, visit the original source. HCI Innovation Group
Related articles
We Need a Cure for AI Health Hype - Time Magazine
Patient-centered financial navigation assistance helps reduce financial toxicity among cancer patients - Medical Xpress
Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!